The phenotype broker: Blockchain and patient phenotype

Last Updated on

July 26, 2019 – “Blockchains for secure digitized medicine”. This is the title of a very interesting and important article in the Journal of Personalised Medine (JPM) as of May 28, 2019.

Blockchain as an emerging technology (particularly around the hype on Bitcoins) has been gaining in popularity, with more possible applications, outside financial fields)  to utilize the technology in the near future. With the offer of a decentralized, distributed environment without the need for a third trusted party (TTP), blockchains are being used to solve issues in systems that are susceptible to cyberattacks. One possible field that could benefit from blockchains that researchers have been focusing on is healthcare.

Current healthcare information systems face several challenges, such as fragmented patient data, centralized systems which are viewed as single points of attacks, and the lack of patient-oriented services. In the present paper, the investigators investigated and analyzed recent literature related to the use of blockchains to tackle issues found in modern healthcare information systems. This was done to understand issues that researchers commonly focus on, to discover remaining areas of concern in any proposed solution, and to understand the possible directions of the integration of blockchains in healthcare and personalized medicine. Background information regarding blockchains and existing healthcare information systems was reviewed, followed by the methodology used in the preparation of the review, where the research questions to consider were stated. Afterwards, an analysis of the results was provided, concluding with a discussion of the remaining issues that need to be focused on, and how blockchains could benefit the healthcare sector and empower personalized medicine.

According to the review and analysis, security and privacy issues in current healthcare systems need to be addressed in order for patients to have more confidence in the medical professional and their respective clinics. One major area that needs to be focused on is the management of electronic medical records (EMR). Digitalizing medical records has eased their storage and sharing. However, there remain issues around unauthorized access and disclosure, the centralized system that can be seen as a single point of attack, and patient medical information fragmentation in the event that multiple healthcare professionals are visited. Of course, the most important question would be, who is the owner of  the medical data of any one individual patient?

In order to address these concerns, researchers are turning towards blockchains.  Technically seen, over time, there have been several developments to the original blockchain infrastructure so that it could be used for more than just cryptocurrencies and financial transactions. Researchers have begun looking into ways that blockchains can be used to improve current healthcare systems. Due to their immutable, transparent, distributed, and decentralized nature, blockchains can be used as a digital ledger to ease communication between patients, caretakers, and insurance companies. Patient data can also be stored in a single file, making it comprehensive and giving caretakers a better overview of the health history of the patient. Moreover, each single piece of medical information of an individual patient could be “individualized”, that is, patients could determine who is authorised to see the information and what for. They could even allocate price tags to such information.

A review of several published proposals for the inclusion of blockchains in healthcare has shown that the digital ledger technology can be used to improve current systems. Data could be distributed and decentralized, preventing it from being lost and allowing it to be recovered in the event of an attack. Audit trails keep track of what transactions and modifications are made to patient records, while notifying all users on the network. Patients will be given more control over who has access to their data by selecting who carries the cryptographic keys required to decrypt and view it.

However, again tonically seen, the sources reviewed in the present article have also mentioned some areas of concern that will need to be addressed, such as issues with scalability. Healthcare systems are expected to handle large amounts of data for a large number of people, and blockchains will need to be able to grow in order to accommodate for such a number to provide seamless service, and exchange of data. End-point security is also a concern, because although blockchains are secure, a single node being compromised may affect the entire chain. With the risk of a node being compromised, issues with key generation and replacement will also need to be addressed so that users can return to using the blockchain as soon as possible.

Overall, the integration of blockchains into healthcare infrastructures shows great potential. Continuing research in this area will be beneficial to healthcare providers, patients, and other involved parties such as research institutions and insurance companies. Once the remaining issues with blockchains are overcome, healthcare systems can evolve for everyone’s benefit. Here, we should mention that the referred to article is pretty technically driven, as far as blockchains are concerned as means of holding patient information. What is not addressed at all is the potential  of blockchains as an individualized means of knowledge and/or evidence brokerage. Imagine you are an individual with a certain genotype who carries particular allelic variants who places this genetic background and his individually resulting phenotype into a system like blockchains. In this system, the individual could, as mentioned above, define whether this information is “private” or “public”. Since pharmaceutical companies are very hot in getting phenotype data from patients, in order to make sense out of their clinical and pharmacovigilance data, they would pay any price for such information. So, in consequence, thanks to blockchain technologies, every individual / patient could become a broker for his own data, being genetic, being phenotypic, being a combination of the two. So, if ever, blockchains may offer a way to “broker” your personal health- and /or disease- and/or genetic predisposition- data at any price you decide upon to pharmaceutical companies, to regulatory bodies, or any one interested in your phenotype. For some rare gene/phenotype relations, in a very competitive environment, the price tags for such informations may become considerably high and tradeable on a future free health data market (FHDM) just as Bitcoins are in the financial markets.

Print Friendly, PDF & Email


Tags: , , , , , , , , , , , , , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Leave a Reply

Optional: Social Subscribe/Login

Notify of

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Researchers identify new gene mutation in familial thyroid cancers November 20, 2019
    Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer. Dr. Darrin Bann, an otolaryngology resident at the College of Medicine and lead author of the study, said that this mutation is the first and only mutation associated with familial thyroid cancer to be […]
  • Researchers develop new database of druggable fusion targets November 20, 2019
    When sections from two separate genes merge due to various factors, such as translocation or splicing, the hybrid that is formed is called a gene fusion. In recent years, it has been discovered that these fusion events play a vital role in the development of cancers and other complex diseases. However, there are very few […]
  • Early results of CRISPR gene-editing treatment shows promise in first human trials November 20, 2019
    Officials from Vertex Pharmaceuticals and CRISPR Therapeutics have announced that preliminary results from testing CRISPR gene-editing treatment in human patients with blood disorders show promise thus far. The joint project between the two firms is taking place at one location in Europe and another in the United States. The results have been posted on the […]
  • Whole-genome sequencing analysis to find more exact biomarkers November 20, 2019
    A new study from Uppsala University shows that whole-genome sequencing increases the precision of genetic studies, which in turn can improve our understanding of how to use biomarkers to discover disease. The results are published in the scientific journal Scientific Reports.
  • Complex organ models grown in the lab November 19, 2019
    Scientists at the University of Würzburg have successfully produced human tissues from stem cells. They have a complexity similar to that of normal tissue and are far superior to previous structures.
  • Outback telescope captures Milky Way center, discovers remnants of dead stars November 20, 2019
    A radio telescope in the Western Australian outback has captured a spectacular new view of the centre of the galaxy in which we live, the Milky Way.The image from the Murchison Widefield Array (MWA) telescope shows what our galaxy would look like if human eyes could see radio waves.
  • Leadership's in the blood for tiny fish November 20, 2019
    Leadership during cooperation runs in the family for tiny fish called Trinidadian guppies, new research shows.
  • Non-invasive microscopy detects activation state and distinguishes between cell types November 20, 2019
    Most analytical methods in biology require invasive procedures to analyze samples, which leads to irreversible changes or even their destruction. Here, researchers from Osaka University develop a non-invasive, label-free optical approach along with statistical tools to reveal immune cell type, cell activation state, and single cell heterogeneity.
  • Living in ethnic enclaves may improve pregnancy outcomes for Asian/Pacific islanders November 20, 2019
    Among Asian/Pacific Islander women living in the United States, those who reside in ethnic enclaves--areas with a high concentration of residents of a similar ancestry--are less likely to have pregnancy or birth complications than those living in other areas, suggests a study by researchers at the National Institutes of Health and other institutions.
  • Study: Young children can learn math skills from intelligent virtual characters November 20, 2019
    A new study examined whether young children's verbal engagement with an onscreen interactive media character could boost their math skills. The study concluded that children's parasocial (that is, one-sided) emotional relationships with the intelligent character and their parasocial interactions (in this case, talking about math with the character) led to quicker, more accurate math responses […]